Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Researchers are comparing KarXT and placebo to find out how the approaches affect psychotic symptoms in young people with schizophrenia.
This study evaluates the safety and effectiveness of KarXT for people with schizophrenia.
A Phase 3 Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride in Children and Adolescents With Psychiatric Disorders
Researchers are comparing EB-1020 (Centanafadine) low dose, EB-1020 (Centanafadine) high dose and placebo to find out how the approaches affect ADHD symptoms in children and adolescents with ADHD.
Effects of the Close Collaboration With Parents Intervention on Parents of Newborns
Researchers are comparing EB-1020 (Centanafadine) 164.4 mg, EB-1020 (Centanafadine) 328.8 mg and placebo, tracking side effects to assess safety in adults with ADHD.
Loving Habits: A Feasibility Study of a Support Program for Building New Parent-child Behavioral Habits
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Researchers are comparing OPC-34712FUM/ Brexpiprazole fumarate and placebo to find out how the approaches affect psychotic symptoms in people with schizophrenia.
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.